Drug Delivery & Environmental Sustainability112

Issue No #112 Sep/Oct 2020 October 1st, 2020

Issue 112 - SepOct 2020

Inside the magazine

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.

FROM DESIGN TO DISPOSAL: ACHIEVING SUSTAINABILITY IN MEDICAL DEVICES

FROM DESIGN TO DISPOSAL: ACHIEVING SUSTAINABILITY IN MEDICAL DEVICES

George I’ons discusses the onus on the device design industry to move towards sustainable practices, including what this entails, how it might be achieved and what benefits sustainability may bring.

PHARMA’S ROLE IN THE GLOBAL ENVIRONMENTAL SUSTAINABILITY MOVEMENT

PHARMA’S ROLE IN THE GLOBAL ENVIRONMENTAL SUSTAINABILITY MOVEMENT

Alex Catino discusses current trends in the pharmaceutical industry in relation to environmental sustainability in healthcare.

SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE

SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE

Rina Chokshi discusses the benefits of naturally derived, sustainable ingredients and their benefits to the environment and pharmaceutical industry.

PRODUCT SHOWCASE: ZwickRoell Luer Lock Testing System

Wolfgang Moersch

PRODUCT SHOWCASE: ZwickRoell Luer Lock Testing System

Wolfgang Moersch provides an update on ZwickRoell's Luer Lock Testing System and describes the company's sustainability policies, it having been carbon neutral since 2014.

CUTTING CARBON IMPACT: CREATING A SUSTAINABLE pMDI COMPONENT SUPPLY CHAIN

CUTTING CARBON IMPACT: CREATING A SUSTAINABLE pMDI COMPONENT SUPPLY CHAIN

Wim Kehoe and Ameet Sule discuss H&T Presspart’s approach to sustainability, and the developments that are helping to reduce the carbon footprint of pMDIs.

LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE

Dr Aline Moulin

Skyepharma Production

LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE

Aline Moulin and Laurent Rigaudeau discuss how Skyepharma fulfils its sustainable development policy through its technologies and processes.

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.

INTERVIEW: ERIK HAEFFLER, RECIPHARM

INTERVIEW: ERIK HAEFFLER, RECIPHARM

In this interview, Erik Haeffler discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety and efficacy standard for achieving its main objective of promoting patient health and wellbeing.

SMART GOALS AND CONTINUOUS IMPROVEMENT FOR A RESILIENT SUSTAINABILITY STRATEGY

SMART GOALS AND CONTINUOUS IMPROVEMENT FOR A RESILIENT SUSTAINABILITY STRATEGY

Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.

NEXT-GENERATION PMDIS: A HOLISTIC, PATIENT-CENTRED APPROACH TO SUSTAINABILITY

Kindeva Drug Delivery

NEXT-GENERATION PMDIS: A HOLISTIC, PATIENT-CENTRED APPROACH TO SUSTAINABILITY

Mike Needham, Phil Cocks and Louise Righton discuss how sustainability should be a central theme of future innovation in inhalation drug delivery but must be balanced with the needs of the patient.

PAVING THE WAY TO ZERO CARBON EMISSION COMBINATION PRODUCTS: THE YPSOMATE ZERO CASE STUDY

Sebastian Gerner

PAVING THE WAY TO ZERO CARBON EMISSION COMBINATION PRODUCTS: THE YPSOMATE ZERO CASE STUDY

Sebastian Gerner and Andreas Schneider discuss the relationship between the medical device industry and the global issue of plastic waste. The authors introduce YpsoMate Zero as a case study, Ypsomed’s net-zero carbon emission prefilled autoinjector.

RETHINKING DRUG DELIVERY DEVICES FOR SUSTAINABILITY AND INNOVATION

RETHINKING DRUG DELIVERY DEVICES FOR SUSTAINABILITY AND INNOVATION

Sergio Malorni and George Bostock discuss the issue of designing for sustainability, including going beyond “Reduce, Reuse, Recycle” to “Rethink” and looking to adjacent and consumer industries for inspiration on innovations the drug delivery industry can adopt with a view to reducing its environmental impact.

SUSTAINABLE POLYMERS FOR HEALTHCARE HELP ADVANCE THE CIRCULAR ECONOMY

SUSTAINABLE POLYMERS FOR HEALTHCARE HELP ADVANCE THE CIRCULAR ECONOMY

Alexander Fix and Hans de Brouwer provide an update on activities undertaken by SABIC's Specialties business to address the need for sustainable materials in the pharma world.

SUSTAINABILITY AND DRUG DELIVERY DEVICES

SUSTAINABILITY AND DRUG DELIVERY DEVICES

Rob Veasey explores the environmental challenges facing the drug delivery device industry – and the opportunities they bring.

COMPANY SHOWCASE: West Pharmaceutical Services

West Pharmaceutical Services

COMPANY SHOWCASE: West Pharmaceutical Services

West describes how it believes that, as a global organisation, it has a duty and obligation to contribute to a sustainable future and that each of its team members, working together, can make a difference.

Top